Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention

Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species...

Full description

Saved in:
Bibliographic Details
Published in:Renal failure Vol. 45; no. 1; p. 2146512
Main Authors: Ma, Xiaoju, Ma, Jingru, Leng, Tian, Yuan, Zhongzhu, Hu, Tingting, Liu, Qiuyan, Shen, Tao
Format: Journal Article
Language:English
Published: England Taylor & Francis 01.12.2023
Taylor & Francis Ltd
Taylor & Francis Group
Subjects:
ISSN:0886-022X, 1525-6049, 1525-6049
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
AbstractList Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
Author Shen, Tao
Ma, Jingru
Ma, Xiaoju
Yuan, Zhongzhu
Leng, Tian
Liu, Qiuyan
Hu, Tingting
Author_xml – sequence: 1
  givenname: Xiaoju
  surname: Ma
  fullname: Ma, Xiaoju
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 2
  givenname: Jingru
  surname: Ma
  fullname: Ma, Jingru
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 3
  givenname: Tian
  surname: Leng
  fullname: Leng, Tian
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 4
  givenname: Zhongzhu
  surname: Yuan
  fullname: Yuan, Zhongzhu
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 5
  givenname: Tingting
  surname: Hu
  fullname: Hu, Tingting
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 6
  givenname: Qiuyan
  surname: Liu
  fullname: Liu, Qiuyan
  organization: School of Public Health, Chengdu University of Traditional Chinese Medicine
– sequence: 7
  givenname: Tao
  surname: Shen
  fullname: Shen, Tao
  organization: School of Basic Medicine, Chengdu University of Traditional Chinese Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36762989$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1vEzEUXKEimhZ-AmglLlwSvPauP4SEqCI-KhVxKRI36639NnHY2MHeBPLv8TYJoj3AxZafZ8bz_OaiOPPBY1E8r8isIpK8JlJyQum3Gc3rjFY1byr6qJhUDW2mnNTqrJiMmOkIOi8uUloRUjVS0CfFOeOCUyXVpFhe2R14g6l0vgy_nIXB7bBMQ8R0V9vAsAwL9JhcKkNXWgctDs6U3531uM_nhJCwBG9L7DpnwOxH3O38c6YPGHfoBxf80-JxB33CZ8f9svj64f3t_NP05svH6_nVzdQ0nA7TGlre2s4ojrbtBOOKWQaiRsZlTbAGIbBhVBDbWiE4NlVTEcpaJFyKugN2WVwfdG2Ald5Et4a41wGcviuEuNAQs_8eNVUCOFCKEklNgELFDVUowWR9zkattwetzbZdozW5kwj9PdH7N94t9SLstFKMCKGywKujQAw_tpgGvXbJYN-Dx7BNmgqRu2ZK1Rn68gF0FbbR56_SVIrcJVOyyqgXfzv6Y-U00Ax4cwCYGFKK2GnjBhgHkA26XldEj_HRp_joMT76GJ_Mbh6wTw_8j_fuwHO-C3ENP0PsrR5g34fYxZwvlzT7t8RvGarcaA
CitedBy_id crossref_primary_10_7717_peerj_18708
crossref_primary_10_1007_s00438_025_02277_z
crossref_primary_10_1016_j_jep_2025_119752
crossref_primary_10_3389_fendo_2025_1603150
crossref_primary_10_3389_fendo_2023_1265372
crossref_primary_10_3389_fendo_2023_1133970
crossref_primary_10_1016_j_jep_2024_119158
crossref_primary_10_3389_fphar_2024_1506398
crossref_primary_10_3390_pharmaceutics16040505
crossref_primary_10_4239_wjd_v16_i2_101538
crossref_primary_10_1016_j_biopha_2025_117976
crossref_primary_10_1038_s41598_024_84462_5
crossref_primary_10_3389_fendo_2024_1451954
crossref_primary_10_3390_biomedicines12030487
crossref_primary_10_1038_s41419_024_06833_0
crossref_primary_10_3389_fimmu_2024_1526465
crossref_primary_10_1002_fsn3_70317
crossref_primary_10_1186_s13098_025_01902_6
crossref_primary_10_1016_j_biopha_2024_117026
crossref_primary_10_1016_j_ijbiomac_2025_143196
crossref_primary_10_1007_s13300_024_01641_3
crossref_primary_10_1111_nep_70073
crossref_primary_10_1016_j_ecoenv_2023_115536
crossref_primary_10_1186_s13020_025_01150_w
crossref_primary_10_30970_vlubs_2025_94_02
crossref_primary_10_4239_wjd_v15_i11_2220
crossref_primary_10_1186_s12882_025_04166_4
crossref_primary_10_1016_j_tiv_2024_105840
crossref_primary_10_1016_j_bioorg_2025_108706
crossref_primary_10_1089_jmf_2024_k_0175
crossref_primary_10_1186_s12920_024_02006_2
crossref_primary_10_3390_medsci13030087
crossref_primary_10_1016_j_lfs_2025_123758
crossref_primary_10_1002_jbt_70302
crossref_primary_10_1016_j_ijbiomac_2025_146353
crossref_primary_10_1186_s13020_024_00903_3
crossref_primary_10_4239_wjd_v15_i2_287
crossref_primary_10_1002_adtp_202300379
crossref_primary_10_1016_j_phymed_2025_156446
crossref_primary_10_1007_s11010_024_05066_1
crossref_primary_10_1016_j_heliyon_2024_e40427
crossref_primary_10_1016_j_dsx_2023_102884
crossref_primary_10_1016_j_jchromb_2024_124378
crossref_primary_10_1080_10799893_2024_2341678
crossref_primary_10_1016_j_ejphar_2024_176715
crossref_primary_10_1007_s10787_025_01790_2
crossref_primary_10_4239_wjd_v15_i3_530
crossref_primary_10_1002_bmc_70143
crossref_primary_10_1186_s10020_024_00881_0
crossref_primary_10_3389_fendo_2025_1596000
crossref_primary_10_3389_fphar_2025_1578400
crossref_primary_10_1016_j_jep_2024_117946
crossref_primary_10_3390_biom14010137
crossref_primary_10_3389_fphar_2024_1480629
crossref_primary_10_1155_jfbc_8388326
crossref_primary_10_1002_agt2_688
crossref_primary_10_1016_j_biopha_2024_116350
crossref_primary_10_3389_fmed_2025_1607701
crossref_primary_10_3390_ijms251810051
crossref_primary_10_1016_j_ijbiomac_2024_138081
crossref_primary_10_1016_j_jff_2024_106188
crossref_primary_10_1016_j_cjac_2024_100446
crossref_primary_10_1016_j_phymed_2025_156410
crossref_primary_10_1038_s40494_025_01663_5
crossref_primary_10_1038_s41574_025_01171_3
crossref_primary_10_4103_apjtb_apjtb_767_24
crossref_primary_10_3390_antiox13030277
crossref_primary_10_1016_j_nano_2025_102856
crossref_primary_10_1111_1440_1681_13846
crossref_primary_10_3390_separations11070195
crossref_primary_10_1080_13813455_2023_2243651
crossref_primary_10_3390_ijms241512378
crossref_primary_10_1016_j_aquatox_2024_106839
crossref_primary_10_3389_fendo_2024_1376813
crossref_primary_10_4239_wjd_v15_i1_92
crossref_primary_10_3389_fphar_2023_1309598
Cites_doi 10.1007/s11655-011-0825-9
10.21037/atm-21-6234
10.1016/j.jep.2014.08.029
10.3390/molecules26216657
10.1142/S0192415X13500249
10.1152/ajprenal.00028.2013
10.1016/j.bbamcr.2011.03.013
10.1210/me.2014-1372
10.1139/Y09-068
10.1016/j.ejphar.2015.04.017
10.1155/2022/7847135
10.1006/bbrc.1995.1156
10.1016/j.ijbiomac.2017.03.124
10.3892/etm.2017.4420
10.4239/wjd.v11.i1.1
10.3892/etm.2012.680
10.1038/s41419-017-0135-z
10.3389/fphar.2021.720387
10.2147/DDDT.S194787
10.1016/j.jnutbio.2020.108515
10.1016/j.diabet.2018.05.010
10.1038/s41401-021-00788-0
10.1016/j.jep.2009.04.021
10.1186/s12872-021-02233-w
10.1002/cbf.1358
10.1016/j.jep.2010.10.012
10.1016/j.jep.2020.112568
10.2147/DMSO.S299375
10.1039/D0FO02335C
10.1016/j.jep.2019.111921
10.1142/S0192415X12500036
10.1016/j.jep.2016.05.033
10.3892/mmr.2021.12231
10.1155/2016/1064924
10.1161/CIRCRESAHA.110.217117
10.1042/CS20190372
10.1111/j.1523-1755.2004.00367.x
10.2147/DDDT.S367624
10.1016/j.ejphar.2018.12.031
10.5582/bst.2017.01104
10.2147/DDDT.S167405
10.1186/1423-0127-18-47
10.1254/jphs.CPJ04005X
10.1016/j.lfs.2021.119197
10.1172/JCI115740
10.2337/db21-1079
10.2147/DDDT.S171286
10.1016/j.phrs.2022.106326
10.1161/CIRCULATIONAHA.120.051898
10.1111/j.1745-7254.2005.00133.x
10.1002/mnfr.201100080
10.1007/s11255-017-1697-5
10.1080/13880209.2019.1688843
10.1155/2020/7950457
10.1038/nrd3871
10.1016/j.tem.2005.03.010
10.1186/s13063-016-1385-2
10.1155/2016/5749857
10.1016/j.jep.2011.10.015
10.1016/j.yexcr.2013.10.006
10.1111/bph.14935
10.1172/JCI66218
10.1155/2018/6806943
10.1016/j.redox.2020.101799
10.1038/jhh.2009.70
10.3389/fphar.2021.638422
10.1038/414813a
10.1007/s11033-012-2321-5
10.2337/db21-0050
10.1016/j.phymed.2018.12.045
10.7150/thno.30640
10.2147/DDDT.S319260
10.1002/mnfr.201600710
10.1016/j.phymed.2013.03.027
10.1080/13813455.2021.1890129
10.1016/j.lfs.2020.118855
10.1055/s-0033-1350649
10.3389/fphys.2020.00073
10.3892/ijmm.2017.3098
10.1038/sj.bjp.0707666
10.1172/JCI118175
10.3389/fphar.2022.841818
10.3389/fcell.2020.00559
10.1016/j.cbi.2011.01.033
10.1155/2016/3140290
10.3390/ijms18040877
10.3390/ijms18050855
10.1186/s12860-019-0202-7
10.2337/db11-0807
10.3390/ijms17081327
10.1016/j.ejphar.2020.173449
10.1016/S0898-6568(99)00071-6
10.1016/j.bbrc.2016.07.115
10.1016/j.biopha.2018.06.088
10.2337/db09-1342
10.1038/srep14733
10.1016/j.jep.2021.114346
10.1016/j.biopha.2017.03.016
10.3892/etm.2016.3483
10.2741/4792
10.1155/2015/390428
10.1186/s40659-018-0157-8
10.2337/diab.44.2.234
10.1002/ptr.5083
10.1016/j.jep.2020.113548
10.1242/jcs.00224
10.1371/journal.pone.0090807
10.2337/db07-1119
10.1097/00075197-200209000-00016
10.3892/etm.2013.1226
10.1155/2015/905749
10.2147/DDDT.S174058
10.3389/fphar.2020.00988
10.2337/db11-1164
10.1155/2020/1903627
10.1515/jpem-2018-0425
10.5582/bst.2018.01009
10.1097/MD.0000000000027569
10.1038/srep35483
10.3892/ijmm.2021.4996
10.1016/j.phrs.2020.104746
10.1097/MNH.0000000000000489
10.1155/2017/1685194
10.3109/0886022X.2013.867798
10.1038/s41598-017-07061-7
10.1053/j.ajkd.2012.06.005
10.1007/s001250051142
10.1038/s41419-021-04184-8
10.1016/j.jep.2017.02.046
ContentType Journal Article
Copyright 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023
2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)
Copyright_xml – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023
– notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1080/0886022X.2022.2146512
DatabaseName Taylor & Francis Journals (OA)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
– sequence: 4
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate X. Ma et al
EISSN 1525-6049
ExternalDocumentID oai_doaj_org_article_297a6a22e8e040a2a16c29e8ac27063a
PMC9930779
36762989
10_1080_0886022X_2022_2146512
2146512
Genre Review
Journal Article
GroupedDBID ---
00X
0YH
123
29P
36B
4.4
53G
5RE
7X7
88E
8FI
8FJ
8G5
ABDBF
ABUWG
ACGEJ
ACGFS
ACUHS
ADBBV
ADCVX
ADRBQ
ADXPE
AENEX
AFKRA
AFKVX
AJWEG
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AQTUD
ARJSQ
AZQEC
BABNJ
BCNDV
BENPR
BLEHA
CCPQU
CS3
DWQXO
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
H13
HMCUK
HZ~
M1P
M2O
M4Z
O9-
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PROAC
PSQYO
RPM
SV3
TDBHL
TFDNU
TFL
TFW
TUS
UKHRP
V1S
~1N
AAYXX
AFFHD
CITATION
.GJ
5VS
AALIY
AAORF
AAPXX
ABWCV
AFLEI
AJVHN
AWYRJ
BPHCQ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
HYE
JENTW
M44
NPM
NUSFT
OK1
PQQKQ
QQXMO
ZGI
ZXP
3V.
7T5
7XB
8FK
H94
K9.
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c562t-4ab6bdfc96edbf73693d3a74e36840e4a77e53270dbd776e5151023be06874fa3
IEDL.DBID DOA
ISICitedReferencesCount 93
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000934343500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0886-022X
1525-6049
IngestDate Fri Oct 03 12:50:50 EDT 2025
Tue Nov 04 02:06:45 EST 2025
Fri Sep 05 13:03:31 EDT 2025
Tue Oct 07 07:27:03 EDT 2025
Thu Jan 02 22:54:13 EST 2025
Tue Nov 18 22:18:53 EST 2025
Sat Nov 29 07:56:23 EST 2025
Mon Oct 20 23:47:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords pathogenesis
Diabetic kidney disease (DKD)
traditional Chinese medicine
oxidative stress
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c562t-4ab6bdfc96edbf73693d3a74e36840e4a77e53270dbd776e5151023be06874fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
These authors contributed equally to this work.
OpenAccessLink https://doaj.org/article/297a6a22e8e040a2a16c29e8ac27063a
PMID 36762989
PQID 2871513981
PQPubID 3933335
ParticipantIDs proquest_miscellaneous_2775623994
doaj_primary_oai_doaj_org_article_297a6a22e8e040a2a16c29e8ac27063a
crossref_primary_10_1080_0886022X_2022_2146512
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9930779
proquest_journals_2871513981
informaworld_taylorfrancis_310_1080_0886022X_2022_2146512
crossref_citationtrail_10_1080_0886022X_2022_2146512
pubmed_primary_36762989
PublicationCentury 2000
PublicationDate 2023-Dec
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-Dec
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Renal failure
PublicationTitleAlternate Ren Fail
PublicationYear 2023
Publisher Taylor & Francis
Taylor & Francis Ltd
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
– name: Taylor & Francis Group
References e_1_3_3_50_1
e_1_3_3_77_1
Lu Q (e_1_3_3_29_1) 2019; 17
e_1_3_3_117_1
e_1_3_3_39_1
Sun WS (e_1_3_3_148_1) 2004; 24
e_1_3_3_16_1
e_1_3_3_35_1
e_1_3_3_58_1
e_1_3_3_92_1
Chen HH (e_1_3_3_141_1) 2021; 2021
e_1_3_3_136_1
e_1_3_3_12_1
e_1_3_3_31_1
e_1_3_3_54_1
e_1_3_3_73_1
e_1_3_3_113_1
Ke-Ke M (e_1_3_3_34_1) 2019; 25
e_1_3_3_61_1
e_1_3_3_88_1
e_1_3_3_9_1
e_1_3_3_105_1
e_1_3_3_128_1
e_1_3_3_109_1
Yi H (e_1_3_3_15_1) 2021; 13
e_1_3_3_27_1
e_1_3_3_46_1
e_1_3_3_69_1
e_1_3_3_80_1
e_1_3_3_120_1
e_1_3_3_147_1
e_1_3_3_5_1
e_1_3_3_23_1
e_1_3_3_42_1
e_1_3_3_65_1
e_1_3_3_84_1
e_1_3_3_101_1
e_1_3_3_124_1
e_1_3_3_30_1
Guo Z-A (e_1_3_3_151_1) 2014; 34
e_1_3_3_99_1
Hao W (e_1_3_3_53_1) 2022; 57
Wang B (e_1_3_3_66_1) 2015; 21
Yuan Y (e_1_3_3_68_1) 2017; 48
Xuqin D (e_1_3_3_110_1) 2019; 37
e_1_3_3_116_1
e_1_3_3_139_1
e_1_3_3_19_1
Cheng-de L (e_1_3_3_97_1) 2018; 34
e_1_3_3_38_1
e_1_3_3_91_1
e_1_3_3_131_1
e_1_3_3_57_1
e_1_3_3_112_1
e_1_3_3_135_1
e_1_3_3_154_1
e_1_3_3_11_1
e_1_3_3_41_1
e_1_3_3_87_1
Hu J (e_1_3_3_134_1) 2014; 80
e_1_3_3_60_1
Song XY (e_1_3_3_142_1) 2004; 24
e_1_3_3_108_1
e_1_3_3_8_1
e_1_3_3_127_1
Renzhi J (e_1_3_3_143_1) 2017; 33
e_1_3_3_49_1
e_1_3_3_100_1
Haotao M. (e_1_3_3_146_1) 2022; 22
e_1_3_3_26_1
e_1_3_3_45_1
e_1_3_3_83_1
e_1_3_3_104_1
e_1_3_3_4_1
e_1_3_3_22_1
e_1_3_3_64_1
e_1_3_3_123_1
e_1_3_3_52_1
e_1_3_3_75_1
e_1_3_3_98_1
e_1_3_3_71_1
e_1_3_3_79_1
e_1_3_3_119_1
e_1_3_3_138_1
e_1_3_3_18_1
e_1_3_3_14_1
e_1_3_3_37_1
e_1_3_3_90_1
e_1_3_3_111_1
e_1_3_3_130_1
e_1_3_3_10_1
e_1_3_3_33_1
e_1_3_3_56_1
e_1_3_3_94_1
e_1_3_3_115_1
Li B-y (e_1_3_3_149_1) 2015; 35
e_1_3_3_153_1
e_1_3_3_40_1
e_1_3_3_63_1
e_1_3_3_86_1
e_1_3_3_7_1
e_1_3_3_107_1
e_1_3_3_25_1
e_1_3_3_48_1
e_1_3_3_122_1
e_1_3_3_3_1
e_1_3_3_21_1
e_1_3_3_44_1
e_1_3_3_67_1
e_1_3_3_82_1
e_1_3_3_103_1
e_1_3_3_126_1
Xi-Mou Z (e_1_3_3_145_1) 2021; 27
e_1_3_3_51_1
e_1_3_3_78_1
e_1_3_3_70_1
e_1_3_3_140_1
Jiang W (e_1_3_3_72_1) 2016; 8
e_1_3_3_118_1
Jing D (e_1_3_3_132_1) 2017; 14
e_1_3_3_17_1
Liu I-M (e_1_3_3_155_1) 2012; 2012
e_1_3_3_133_1
e_1_3_3_156_1
e_1_3_3_13_1
e_1_3_3_59_1
e_1_3_3_36_1
e_1_3_3_93_1
e_1_3_3_114_1
e_1_3_3_137_1
e_1_3_3_55_1
e_1_3_3_32_1
e_1_3_3_74_1
Fu-Tuan G (e_1_3_3_95_1) 2016; 32
e_1_3_3_62_1
e_1_3_3_89_1
Xiao-Ling G (e_1_3_3_96_1) 2018; 34
Liu S (e_1_3_3_150_1) 2008; 33
Li MZ (e_1_3_3_152_1) 2012; 32
e_1_3_3_6_1
e_1_3_3_129_1
Xu X-H (e_1_3_3_76_1) 2017; 21
e_1_3_3_106_1
e_1_3_3_28_1
e_1_3_3_24_1
e_1_3_3_121_1
e_1_3_3_47_1
e_1_3_3_81_1
e_1_3_3_2_1
e_1_3_3_20_1
e_1_3_3_125_1
e_1_3_3_43_1
e_1_3_3_85_1
e_1_3_3_102_1
e_1_3_3_144_1
References_xml – ident: e_1_3_3_128_1
  doi: 10.1007/s11655-011-0825-9
– ident: e_1_3_3_125_1
  doi: 10.21037/atm-21-6234
– ident: e_1_3_3_140_1
  doi: 10.1016/j.jep.2014.08.029
– ident: e_1_3_3_122_1
  doi: 10.3390/molecules26216657
– ident: e_1_3_3_139_1
  doi: 10.1142/S0192415X13500249
– ident: e_1_3_3_83_1
  doi: 10.1152/ajprenal.00028.2013
– ident: e_1_3_3_25_1
  doi: 10.1016/j.bbamcr.2011.03.013
– ident: e_1_3_3_33_1
  doi: 10.1210/me.2014-1372
– ident: e_1_3_3_94_1
  doi: 10.1139/Y09-068
– ident: e_1_3_3_100_1
  doi: 10.1016/j.ejphar.2015.04.017
– ident: e_1_3_3_93_1
  doi: 10.1155/2022/7847135
– ident: e_1_3_3_20_1
  doi: 10.1006/bbrc.1995.1156
– ident: e_1_3_3_26_1
  doi: 10.1016/j.ijbiomac.2017.03.124
– ident: e_1_3_3_47_1
  doi: 10.3892/etm.2017.4420
– ident: e_1_3_3_4_1
  doi: 10.4239/wjd.v11.i1.1
– ident: e_1_3_3_156_1
  doi: 10.3892/etm.2012.680
– ident: e_1_3_3_19_1
  doi: 10.1038/s41419-017-0135-z
– volume: 80
  start-page: 614
  issue: 8
  year: 2014
  ident: e_1_3_3_134_1
  article-title: Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy
  publication-title: Planta Med
– volume: 21
  start-page: 36
  issue: 1
  year: 2015
  ident: e_1_3_3_66_1
  article-title: The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis
  publication-title: Altern Ther Health Med
– ident: e_1_3_3_81_1
  doi: 10.3389/fphar.2021.720387
– ident: e_1_3_3_24_1
  doi: 10.2147/DDDT.S194787
– volume: 34
  start-page: 1047
  issue: 9
  year: 2014
  ident: e_1_3_3_151_1
  article-title: Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by qizhi jiangtang capsule: a multicenter randomized control clinical study
  publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi
– ident: e_1_3_3_86_1
  doi: 10.1016/j.jnutbio.2020.108515
– ident: e_1_3_3_73_1
  doi: 10.1016/j.diabet.2018.05.010
– ident: e_1_3_3_123_1
  doi: 10.1038/s41401-021-00788-0
– ident: e_1_3_3_144_1
  doi: 10.1016/j.jep.2009.04.021
– ident: e_1_3_3_35_1
  doi: 10.1186/s12872-021-02233-w
– ident: e_1_3_3_14_1
  doi: 10.1002/cbf.1358
– volume: 17
  start-page: 835
  issue: 1
  year: 2019
  ident: e_1_3_3_29_1
  article-title: ROS induces epithelial-mesenchymal transition via the TGF-β1/PI3K/Akt/mTOR pathway in diabetic nephropathy
  publication-title: Exp Ther Med
– ident: e_1_3_3_111_1
  doi: 10.1016/j.jep.2010.10.012
– volume: 35
  start-page: 142
  issue: 2
  year: 2015
  ident: e_1_3_3_149_1
  article-title: Efficacy observation of treating diabetic nephropathy by shenshuaining granule combined telmisartan tablet
  publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi
– ident: e_1_3_3_108_1
  doi: 10.1016/j.jep.2020.112568
– ident: e_1_3_3_131_1
  doi: 10.2147/DMSO.S299375
– ident: e_1_3_3_78_1
  doi: 10.1039/D0FO02335C
– ident: e_1_3_3_109_1
  doi: 10.1016/j.jep.2019.111921
– ident: e_1_3_3_106_1
  doi: 10.1142/S0192415X12500036
– ident: e_1_3_3_138_1
  doi: 10.1016/j.jep.2016.05.033
– volume: 8
  start-page: 329
  issue: 2
  year: 2016
  ident: e_1_3_3_72_1
  article-title: Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice
  publication-title: Am J Transl Res
– volume: 24
  start-page: 1087
  issue: 12
  year: 2004
  ident: e_1_3_3_142_1
  article-title: Effect of Liuwei Dihuang Pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients
  publication-title: . Zhongguo Zhong Xi Yi Jie He Za Zhi
– ident: e_1_3_3_62_1
  doi: 10.3892/mmr.2021.12231
– ident: e_1_3_3_59_1
  doi: 10.1155/2016/1064924
– volume: 14
  start-page: 5163
  issue: 5
  year: 2017
  ident: e_1_3_3_132_1
  article-title: Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways
  publication-title: Exp Ther Med
– volume: 25
  start-page: 74
  issue: 02
  year: 2019
  ident: e_1_3_3_34_1
  article-title: Effect of astragaloside IV on regulation of PI3K/akt/FoxO1 signal in kidney of type 2 diabetic nephropathy rats
  publication-title: Chin J Exp Trad Med Formulae
– ident: e_1_3_3_22_1
  doi: 10.1161/CIRCRESAHA.110.217117
– ident: e_1_3_3_27_1
  doi: 10.1042/CS20190372
– ident: e_1_3_3_52_1
  doi: 10.1111/j.1523-1755.2004.00367.x
– ident: e_1_3_3_61_1
  doi: 10.2147/DDDT.S367624
– ident: e_1_3_3_85_1
  doi: 10.1016/j.ejphar.2018.12.031
– ident: e_1_3_3_118_1
  doi: 10.5582/bst.2017.01104
– ident: e_1_3_3_130_1
  doi: 10.2147/DDDT.S167405
– volume: 33
  start-page: 68
  issue: 1
  year: 2008
  ident: e_1_3_3_150_1
  article-title: Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy
  publication-title: Zhongguo Zhong Yao Za Zhi
– ident: e_1_3_3_75_1
  doi: 10.1186/1423-0127-18-47
– ident: e_1_3_3_12_1
  doi: 10.1254/jphs.CPJ04005X
– ident: e_1_3_3_84_1
  doi: 10.1016/j.lfs.2021.119197
– ident: e_1_3_3_21_1
  doi: 10.1172/JCI115740
– ident: e_1_3_3_23_1
  doi: 10.2337/db21-1079
– ident: e_1_3_3_126_1
  doi: 10.2147/DDDT.S171286
– ident: e_1_3_3_9_1
  doi: 10.1016/j.phrs.2022.106326
– ident: e_1_3_3_3_1
  doi: 10.1161/CIRCULATIONAHA.120.051898
– ident: e_1_3_3_69_1
  doi: 10.1111/j.1745-7254.2005.00133.x
– volume: 33
  start-page: 176
  issue: 04
  year: 2017
  ident: e_1_3_3_143_1
  article-title: Clinical efficacy of wuling powder combined with rosiglitazone on diabetic nephropathy
  publication-title: Pharma Clin Chin Materia Medica
– ident: e_1_3_3_87_1
  doi: 10.1002/mnfr.201100080
– ident: e_1_3_3_90_1
  doi: 10.1007/s11255-017-1697-5
– ident: e_1_3_3_88_1
  doi: 10.1080/13880209.2019.1688843
– ident: e_1_3_3_10_1
  doi: 10.1155/2020/7950457
– ident: e_1_3_3_17_1
  doi: 10.1038/nrd3871
– ident: e_1_3_3_31_1
  doi: 10.1016/j.tem.2005.03.010
– volume: 27
  start-page: 169
  issue: 18
  year: 2021
  ident: e_1_3_3_145_1
  article-title: Fermented cordyceps powder combined with ACEI/ARB in treatment of diabetic kidney disease:a systematic review
  publication-title: Chin J Exp Trad Med Form
– ident: e_1_3_3_133_1
  doi: 10.1186/s13063-016-1385-2
– ident: e_1_3_3_60_1
  doi: 10.1155/2016/5749857
– ident: e_1_3_3_80_1
  doi: 10.1016/j.jep.2011.10.015
– ident: e_1_3_3_129_1
  doi: 10.1016/j.yexcr.2013.10.006
– ident: e_1_3_3_104_1
  doi: 10.1111/bph.14935
– ident: e_1_3_3_54_1
  doi: 10.1172/JCI66218
– volume: 21
  start-page: 4952
  issue: 21
  year: 2017
  ident: e_1_3_3_76_1
  article-title: Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy
  publication-title: Eur Rev Med Pharmacol Sci
– ident: e_1_3_3_147_1
  doi: 10.1155/2018/6806943
– volume: 32
  start-page: 1675
  issue: 12
  year: 2012
  ident: e_1_3_3_152_1
  article-title: Effects of qiwei granule on the protein and mRNA expressions of renal tissue transforming growth factor-beta1 in KK-Ay mice with spontaneous type 2 diabetes mellitus
  publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi
– ident: e_1_3_3_18_1
  doi: 10.1016/j.redox.2020.101799
– ident: e_1_3_3_5_1
  doi: 10.1038/jhh.2009.70
– ident: e_1_3_3_114_1
  doi: 10.3389/fphar.2021.638422
– ident: e_1_3_3_2_1
– ident: e_1_3_3_7_1
  doi: 10.1038/414813a
– ident: e_1_3_3_102_1
  doi: 10.1007/s11033-012-2321-5
– volume: 48
  start-page: 1386
  issue: 07
  year: 2017
  ident: e_1_3_3_68_1
  article-title: Inhibition of puerarin on formation of advanced glycation end products in vivo and in vitro
  publication-title: Chinese Traditional and Herbal Drugs
– ident: e_1_3_3_57_1
  doi: 10.2337/db21-0050
– ident: e_1_3_3_41_1
  doi: 10.1016/j.phymed.2018.12.045
– ident: e_1_3_3_98_1
  doi: 10.7150/thno.30640
– ident: e_1_3_3_40_1
  doi: 10.2147/DDDT.S319260
– volume: 22
  start-page: 27
  issue: 07
  year: 2022
  ident: e_1_3_3_146_1
  article-title: Effects of Jinshuibao capsule combined with compound α-keto acid tablets on endothelial function and renal artery blood flow in patients with diabetic nephropathy
  publication-title: Pract Clin J Integr Trad Chin Western Med
– ident: e_1_3_3_55_1
  doi: 10.1002/mnfr.201600710
– ident: e_1_3_3_71_1
  doi: 10.1016/j.phymed.2013.03.027
– volume: 32
  start-page: 1148
  issue: 08
  year: 2016
  ident: e_1_3_3_95_1
  article-title: The anti-oxidative effect of ramulus mori polysaccharides on diabetic nephropathy mice
  publication-title: Chin Pharmacol Bull
– ident: e_1_3_3_42_1
  doi: 10.1080/13813455.2021.1890129
– ident: e_1_3_3_50_1
  doi: 10.1016/j.lfs.2020.118855
– ident: e_1_3_3_120_1
  doi: 10.1055/s-0033-1350649
– ident: e_1_3_3_67_1
  doi: 10.3389/fphys.2020.00073
– ident: e_1_3_3_51_1
  doi: 10.3892/ijmm.2017.3098
– ident: e_1_3_3_89_1
  doi: 10.1038/sj.bjp.0707666
– ident: e_1_3_3_13_1
  doi: 10.1172/JCI118175
– ident: e_1_3_3_74_1
  doi: 10.3389/fphar.2022.841818
– ident: e_1_3_3_79_1
  doi: 10.3389/fcell.2020.00559
– volume: 34
  start-page: 388
  issue: 03
  year: 2018
  ident: e_1_3_3_96_1
  article-title: Effect of astragalus polysaccharides on apoptosis, transdifferentiation and ROS content in renal tubular epithelial cells of diabetic nephropathy
  publication-title: Chin J Immunol
– ident: e_1_3_3_77_1
  doi: 10.1016/j.cbi.2011.01.033
– ident: e_1_3_3_92_1
  doi: 10.1155/2016/3140290
– volume: 34
  start-page: 512
  issue: 04
  year: 2018
  ident: e_1_3_3_97_1
  article-title: Effects of astragalus polysaccharide on renal TGF-β1/smads signaling pathway in rats with diabetes mellitus
  publication-title: Chin Pharmacol Bull
– ident: e_1_3_3_44_1
  doi: 10.3390/ijms18040877
– ident: e_1_3_3_48_1
  doi: 10.3390/ijms18050855
– ident: e_1_3_3_49_1
  doi: 10.1186/s12860-019-0202-7
– ident: e_1_3_3_38_1
  doi: 10.2337/db11-0807
– ident: e_1_3_3_103_1
  doi: 10.3390/ijms17081327
– volume: 37
  start-page: 869
  issue: 04
  year: 2019
  ident: e_1_3_3_110_1
  article-title: Astragalus injection for early diabetic nephropathoes:a meta-analysis
  publication-title: Chin Arch Trad Chin Med
– ident: e_1_3_3_56_1
  doi: 10.1016/j.ejphar.2020.173449
– ident: e_1_3_3_46_1
  doi: 10.1016/S0898-6568(99)00071-6
– ident: e_1_3_3_32_1
  doi: 10.1016/j.bbrc.2016.07.115
– ident: e_1_3_3_30_1
  doi: 10.1016/j.biopha.2018.06.088
– ident: e_1_3_3_39_1
  doi: 10.2337/db09-1342
– ident: e_1_3_3_45_1
  doi: 10.1038/srep14733
– ident: e_1_3_3_107_1
  doi: 10.1016/j.jep.2021.114346
– volume: 57
  start-page: 1189
  issue: 08
  year: 2022
  ident: e_1_3_3_53_1
  article-title: Berberine inhibits JAK2/STAT3 signaling pathway to alleviate high glucose induced podocyte EMT and apoptosis
  publication-title: Acta Universitatis Medicinalis Anhui
– ident: e_1_3_3_121_1
  doi: 10.1016/j.biopha.2017.03.016
– ident: e_1_3_3_70_1
  doi: 10.3892/etm.2016.3483
– ident: e_1_3_3_154_1
  doi: 10.2741/4792
– ident: e_1_3_3_63_1
  doi: 10.1155/2015/390428
– ident: e_1_3_3_105_1
  doi: 10.1186/s40659-018-0157-8
– ident: e_1_3_3_8_1
  doi: 10.2337/diab.44.2.234
– volume: 2012
  start-page: 140103
  year: 2012
  ident: e_1_3_3_155_1
  article-title: Beneficial effect of traditional chinese medicinal formula danggui-shaoyao-san on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats
  publication-title: Evid Based Complement Alternat Med
– ident: e_1_3_3_65_1
  doi: 10.1002/ptr.5083
– ident: e_1_3_3_137_1
  doi: 10.1016/j.jep.2020.113548
– ident: e_1_3_3_28_1
  doi: 10.1242/jcs.00224
– ident: e_1_3_3_153_1
  doi: 10.1371/journal.pone.0090807
– ident: e_1_3_3_16_1
  doi: 10.2337/db07-1119
– ident: e_1_3_3_6_1
  doi: 10.1097/00075197-200209000-00016
– ident: e_1_3_3_64_1
  doi: 10.3892/etm.2013.1226
– ident: e_1_3_3_99_1
  doi: 10.1155/2015/905749
– ident: e_1_3_3_116_1
  doi: 10.2147/DDDT.S174058
– volume: 2021
  start-page: 1298487
  year: 2021
  ident: e_1_3_3_141_1
  article-title: Liu Wei Di Huang Wan and the Delay of insulin use in patients with type 2 diabetes in Taiwan: a nationwide study
  publication-title: Evid Based Complement Alternat Med
– ident: e_1_3_3_112_1
  doi: 10.3389/fphar.2020.00988
– volume: 13
  start-page: 282
  issue: 03
  year: 2021
  ident: e_1_3_3_15_1
  article-title: Relationship between OGlcNAcylation and diabetic nephropathy
  publication-title: Chin J Diabetes
– ident: e_1_3_3_101_1
  doi: 10.2337/db11-1164
– ident: e_1_3_3_124_1
  doi: 10.1155/2020/1903627
– ident: e_1_3_3_91_1
  doi: 10.1515/jpem-2018-0425
– volume: 24
  start-page: 704
  issue: 8
  year: 2004
  ident: e_1_3_3_148_1
  article-title: Clinical study on effect of tongluo capsule in treating diabetic nephropathy caused chronic renal failure
  publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi
– ident: e_1_3_3_119_1
  doi: 10.5582/bst.2018.01009
– ident: e_1_3_3_135_1
  doi: 10.1097/MD.0000000000027569
– ident: e_1_3_3_11_1
  doi: 10.1038/srep35483
– ident: e_1_3_3_117_1
  doi: 10.3892/ijmm.2021.4996
– ident: e_1_3_3_127_1
  doi: 10.1016/j.phrs.2020.104746
– ident: e_1_3_3_36_1
  doi: 10.1097/MNH.0000000000000489
– ident: e_1_3_3_43_1
  doi: 10.1155/2017/1685194
– ident: e_1_3_3_113_1
  doi: 10.3109/0886022X.2013.867798
– ident: e_1_3_3_115_1
  doi: 10.1038/s41598-017-07061-7
– ident: e_1_3_3_82_1
  doi: 10.1053/j.ajkd.2012.06.005
– ident: e_1_3_3_37_1
  doi: 10.1007/s001250051142
– ident: e_1_3_3_58_1
  doi: 10.1038/s41419-021-04184-8
– ident: e_1_3_3_136_1
  doi: 10.1016/j.jep.2017.02.046
SSID ssj0015872
Score 2.608253
SecondaryResourceType review_article
Snippet Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2146512
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Apoptosis
Autophagy
Diabetes
Diabetes Mellitus
Diabetic kidney disease (DKD)
Diabetic Nephropathies - drug therapy
Diabetic Nephropathies - etiology
End-stage renal disease
Endothelial cells
Fibrosis
Glycosides
Humans
Kidney - pathology
Kidney diseases
MAP kinase
Medicine, Chinese Traditional
NF-κB protein
Oxidation
Oxidative Stress
Pathogenesis
Phosphatidylinositol 3-Kinases - metabolism
Protein kinase C
Reactive oxygen species
Review
State-of-the-Art Review
Traditional Chinese medicine
Transforming growth factor-b1
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFiEuvB-BgozENWVjJ36cUFu14tJVhYq0N8uxnTYCJWWzRfTf40mcsFsheuCaOJJHMx5_9ky-D-BDgU4V4aTKM2_T3PgqLTnKvdiMhTNROAF424tNiMVCLpfqNF64dbGtcsyJfaJ2rcU78o-I7IsAV2T26fJHiqpRWF2NEhp3YQeZyvIZ7BwcLU6_THWEQvbyTWEpYastXY7_8CC7tkT5JboMZ0RK91Dfusjo1u7Uk_jfoDD9GxC92U-5sUEdP_pf0x7DwwhNyf4QS0_gjm-ewv2TWHx_Bhf7Q79AR-qGtL9q13OGk-FvE3yG6sbtOSbPuiNtRYZ73dqSb7Vr_DWJxSBiGkc8UlcYe43jzg5PSL3Re_kcvh4fnR1-TqNQQ2oDfFoHF5e8dJVV3LuyEowr5pgRuWdIJeNzI4QvGBVzVzohuA8YChkjSj_nUuSVYS9g1rSNfwXEiCoXVpaSOZUXtiqVc4rJoigDsCi5SiAfHaRtZDFHMY3vOhvJTqNfNfpVR78msDd9djnQeNz2wQF6fxqMLNz9g3Z1ruOi1lQJww2lXvqQCw01GbdUeWlssJUzk4DajB297i9hqkExRbNbJrA7BouOaaXTfyIlgffT65AQsMpjGt9ehTFCIKZVKk_g5RCXkxVIz4eU-wmIrYjdMnP7TVNf9KTjAcfOhVCv_z2tN_AgGMGGfp9dmK1XV_4t3LM_13W3ehdX529mHj5A
  priority: 102
  providerName: ProQuest
– databaseName: Taylor & Francis Journals Complete
  dbid: TFW
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAX3o9AQUbimrKJEz-OpWLFpRWHRezN8ittBEqqzRbRf8-M40S7FagHOCa2I489Hs_Yk-8j5H2NkyogUuVFcHllQpNbjnQvrmAQE0EEEFwkmxBnZ3K9Vl9SNuGQ0ioxhm5GoIhoq3FxGztMGXEfYGFw2HrWEN2V5REyU9eRZxi2fuQwWC2_zfcItYz0TdgixybTPzx_-8re7hRB_G9AmP7JEb2ZT7mzQS0f_gfRHpEHyTulx6M6PSZ3QveE3DtN9-9PycXxmDIw0Laj_a_WR9hwOv5wgu-Q4Lg_R_vZDrRv6Hi02zr6vfVduKbpPohCB2lA9ArjrrHe6uSUtjvpl8_I1-Wn1cnnPHE15A48qC3MsuXWN07x4G0jGFfMMyOqwBBNJlRGiFCzUiy89ULwAG4UgkbYsOBSVI1hz8lB13fhJaFGNJVw0krmVVW7xirvFZN1bcG3sFxlpJrmSLsEZI58Gj90MeGdplHUOIo6jWJGjuZmlyOSx20NPqICzJURiDu-6DfnOq1rXSphuCnLIAOYQ1OagrtSBWkcyMqZyYjaVR-9jecwzUiaotktHTicdE0nyzJojHBrcNtlkZF3czHYBLzoMV3or6COEOjWKlVl5MWomrMUiNCHqPsZEXtKuyfmfknXXkTccXBlF0KoV_8g0mtyHx7ZmA90SA62m6vwhtx1P7ftsHkb1-5vWro_Xg
  priority: 102
  providerName: Taylor & Francis
Title Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
URI https://www.tandfonline.com/doi/abs/10.1080/0886022X.2022.2146512
https://www.ncbi.nlm.nih.gov/pubmed/36762989
https://www.proquest.com/docview/2871513981
https://www.proquest.com/docview/2775623994
https://pubmed.ncbi.nlm.nih.gov/PMC9930779
https://doaj.org/article/297a6a22e8e040a2a16c29e8ac27063a
Volume 45
WOSCitedRecordID wos000934343500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: 7X7
  dateStart: 20171101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: BENPR
  dateStart: 20171101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: PIMPY
  dateStart: 20171101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: M2O
  dateStart: 20171101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVAWR
  databaseName: Taylor & Francis Journals Complete
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: TFW
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
– providerCode: PRVAWR
  databaseName: Taylor & Francis Open Access
  customDbUrl:
  eissn: 1525-6049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015872
  issn: 0886-022X
  databaseCode: 0YH
  dateStart: 19870101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLZgIMQF8ZvAqIzEtaOxE_84btOqcWipUBHZyXJsZ4tACVo7xP573nOSqp2QeuFiqY6jxn7PyffyXr6PkI85GlVCpCrS4MaZDdW4FCj34lIOMRFEAMFFsQk5n6ui0IstqS-sCevogbuF-8S0tMIyFlQAf7PMpsIxHZR1DP6CR2gEqGcIpvr8Qa6ibBNsISyxZcXw7Q6yaiuUXWIFxIaMHaGudZ6ynadSJO-_Q136LwB6t45y68E0fUqe9IiSHnczeUbuheY5eTTrc-YvyNVxl-Zf0bqh7Z_aR6pv2n0kgn0oStxe4j2vXtG2ot3r2NrRH7Vvwi3tczjUNp4GZJyw7hbHLU9ntN4qmXxJvk3Plqfn415fYewA9azBMqUofeW0CL6sJBeae25lFjgywITMShlyDsvsSy-lCAB9kOihDBOhZFZZ_oocNG0T3hBqZZVJp0rFvc5yV5Xae81VnpeAB0qhE5IN62tcTz6OGhg_TTpwlPZmMWgW05slIUeb03517Bv7TjhB420GI3l27ACXMr1LmX0ulRC9bXqzju9Oqk7oxPA9F3A4-Inp7wYrg1FpDlBbpQn5sDkM-xiTM7YJ7Q2MkRKhqNZZQl53brWZBbLqIVN-QuSOw-1Mc_dIU19FrnCAnxMp9dv_sS7vyGOYKu-KeQ7Jwfr6JrwnD93vdb26HpH7k4tzaGUhY6tG5MHJ2XzxdRS3JrQz9gX6Fp9niwv4tZx-_wutBjZz
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALb0qggJHgmHZjJ3Z8QKgUqlbtrjgsUm7GsZ02okrK7hbYP8VvxJPHslsheuqBa-JEnmSe9vj7AF4n-FOFr1R55EwYa1eEOUe6FxMxXxP5CsCZhmxCjEZplslPa_CrPwuDbZW9T2wcta0NrpFvY2af-HQljd6dfQuRNQp3V3sKjVYtDt38hy_Zpm8PPvj_-4bSvY_j3f2wYxUIjY_1Mz-fnOe2MJI7mxeCccks0yJ2DHFPXKyFcAmjYmBzKwR3PuAjvEHuBjwVcaGZf-81uO79uMAWMpEtCrwoSRuyKG-42NhLs_7EEGJ5p0j2RDNfkVK6hWzaSURXYmFDGXABMPVvae_F7s2lcLh393_7kPfgTpd4k53WUu7DmqsewM1h11rwEE522m6IKSkrUv8sbYOITtqzNHgNuZvrYwwN5ZTUBWlXrUtDvpa2cnPSbXURXVniEJhDmzmOG-8OSbnUWfoIPl-JnI9hvaor9wSIFkUsTJqnzMo4MUUurZUsTZLcp005lwHEvUIo02G0I1XIqYp6KNdOjxTqker0KICtxWNnLUjJZQ-8R21bDEaM8eZCPTlWnctSXsE115S61HlPr6mOuKHSpdp4WTnTAchlXVWzZompaPlgFLtkApu9cqrOaU7VH80M4NXitnd3uIelK1ef-zFCYMYuZRzARmsHCykQfBAJBQIQKxayIubqnao8aSDVfZY-EEI-_fe0XsKt_fHwSB0djA6fwW0vEGs7mzZhfTY5d8_hhvk-K6eTF41fIPDlqu3nN80JmZ4
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hgiou5Q2BAkbiumUTJ3Z8LIUVCLrqYRF7s_xsI1BSbbYV_fd4EifarUA9wNWPKGOPx9_Y428A3hY4qTx4qix1ZpIr5yeaYboXk9LgEwUPwJku2QSfz8vlUpzEaMI2hlWiD-17oojOVuPiPrd-iIh7FxYGC1vPMnh3WXaAmakLzDN8O0Bnhv7XYvZ9vEgoyi5_E3aZYJ_hEc_fPrO1PXUs_tc4TP-ERK8HVG7sULN7_0G2-7AX4Sk57PXpAdxy9UPYPY4X8I_g7LCPGWhJVZPmV2U73nDSvzjBMsxw3JyiAa1a0njSn-1WhvyobO2uSLwQIuEHiUP6CmWusN3i6JhUG_GXj-Hb7OPi6NMkJmuYmACh1mGaNdPWG8Gc1Z5TJqiliueOIp2MyxXnrqAZn1ptOWcu4ChkjdBuykqee0WfwE7d1O4ZEMV9zk2pS2pFXhivhbWClkWhA7jQTCSQD3MkTWQyx4QaP2U6EJ7GUZQ4ijKOYgIHY7fznsrjpg7vUQHGxsjE3RU0q1MZF7bMBFdMZZkrXbCHKlMpM5lwpTJBVkZVAmJTfeS6O4jxfdYUSW_4gf1B12Q0La1EF7cIuL1ME3gzVgejgDc9qnbNRWjDOeJaIfIEnvaqOUqBFH1Iu58A31LaLTG3a-rqrCMeD1h2yrl4_g8ivYbdkw8z-fXz_MsLuBtqaB8btA8769WFewl3zOW6alevumX8G2vxQjo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+in+oxidative+stress+in+pathogenesis+of+diabetic+kidney+disease+and+efficacy+of+TCM+intervention&rft.jtitle=Renal+failure&rft.au=Ma%2C+Xiaoju&rft.au=Ma%2C+Jingru&rft.au=Leng%2C+Tian&rft.au=Yuan%2C+Zhongzhu&rft.date=2023-12-01&rft.issn=0886-022X&rft.eissn=1525-6049&rft.volume=45&rft.issue=1&rft_id=info:doi/10.1080%2F0886022X.2022.2146512&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_0886022X_2022_2146512
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0886-022X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0886-022X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0886-022X&client=summon